Associated Papers
Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma.
Block T et al.
Frontiers in Oncology, 2022
36582804 (PubMed )
Supplement: Table_2.xlsx › Sheet1
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › M121224
Select a paper to view details